Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics

Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics
Presentation by Robert A. Copeland, Ph.D., Epizyme, Inc.
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 21, 2013, Boston, MA

To download the presentation click here or view the presentation below.

slide1

Picture 1 of 27